2-Pyridinylmethylsulfinylbenzimidazoles
"2-Pyridinylmethylsulfinylbenzimidazoles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that contain benzimidazole joined to a 2-methylpyridine via a sulfoxide linkage. Several of the compounds in this class are ANTI-ULCER AGENTS that act by inhibiting the POTASSIUM HYDROGEN ATPASE found in the PROTON PUMP of GASTRIC PARIETAL CELLS.
| Descriptor ID |
D053799
|
| MeSH Number(s) |
D02.886.640.074 D03.383.725.024 D03.633.100.103.034
|
| Concept/Terms |
2-Pyridinylmethylsulfinylbenzimidazoles- 2-Pyridinylmethylsulfinylbenzimidazoles
- 2 Pyridinylmethylsulfinylbenzimidazoles
- Benzimidazole Methylpyridine Sulfoxides
- Methylpyridine Sulfoxides, Benzimidazole
- Sulfoxides, Benzimidazole Methylpyridine
Timoprazole Derivatives- Timoprazole Derivatives
- Timoprazoles
- 2-Methylpyridine 2-Benzimidazole Sulfoxides
- 2 Methylpyridine 2 Benzimidazole Sulfoxides
- 2-Benzimidazole Sulfoxides, 2-Methylpyridine
- Sulfoxides, 2-Methylpyridine 2-Benzimidazole
- 2-Pyridinylmethylsulfinyl-2-Benzimidazoles
- 2 Pyridinylmethylsulfinyl 2 Benzimidazoles
|
Below are MeSH descriptors whose meaning is more general than "2-Pyridinylmethylsulfinylbenzimidazoles".
Below are MeSH descriptors whose meaning is more specific than "2-Pyridinylmethylsulfinylbenzimidazoles".
This graph shows the total number of publications written about "2-Pyridinylmethylsulfinylbenzimidazoles" by people in this website by year, and whether "2-Pyridinylmethylsulfinylbenzimidazoles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 3 | 0 | 3 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "2-Pyridinylmethylsulfinylbenzimidazoles" by people in Profiles.
-
Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA. 2016 May 17; 315(19):2104-12.
-
In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine. Digestion. 2012; 86(2):171-7.
-
Treatment of Helicobacter pylori in Latin America. Lancet. 2012 Feb 04; 379(9814):408; author reply 408-9.
-
Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA. 2012 Jan 25; 307(4):373-81.
-
Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days. Helicobacter. 2011 Aug; 16(4):295-300.
-
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011 Oct; 141(4):1314-22, 1322.e1-5.
-
Effect of proton pump inhibitor pantoprazole on growth and morphology of oral Lactobacillus strains. Laryngoscope. 2008 Apr; 118(4):599-604.
-
Failures in a proton pump inhibitor therapeutic substitution program: lessons learned. Dig Dis Sci. 2007 Oct; 52(10):2813-20.
-
Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr. 2007 Mar; 150(3):262-7, 267.e1.
-
Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. Aliment Pharmacol Ther. 2006 Jan 15; 23(2):295-301.